Previous 10 | Next 10 |
NORTHAMPTON, MA / ACCESSWIRE / May 2, 2023 / Alkermes Athlone site recently received a 2023 award in the Life Sciences category at Ireland's 2023 Health & Safety Excellence Awards. This recognition is a testament to our employees' focus on building a culture of safety and risk management in ...
NORTHAMPTON, MA / ACCESSWIRE / May 1, 2023 / The 2023 Alkermes Inspiration Grants® program is now open for applications! These grants are designed to support programs or organizations for people affected by serious mental illness, addiction and cancer. Apply here: https://www.alkermes.com/...
2023-04-26 17:05:18 ET Alkermes plc (ALKS) Q1 2023 Earnings Conference Call April 26, 2023 08:00 ET Company Participants Sandra Coombs - Senior Vice President of Investor Relations and Corporate Affairs Richard Pops - Chief Executive Officer Iain Brown - Chief Fi...
NORTHAMPTON, MA / ACCESSWIRE / April 26, 2023 / Patients diagnosed with platinum-resistant Ovarian Cancer (PROC) often face poor prognosis due to the limited treatment options. Watch this video to learn more about PROC and why clinical trials are critical for researching potential options. Vie...
2023-04-26 07:04:24 ET Alkermes press release ( NASDAQ: ALKS ): Q1 Non-GAAP EPS of $0.01 beats by $0.02 . Revenue of $287.6M (+3.3% Y/Y) beats by $6.41M . Net sales of proprietary products for the quarter increased approximately 25% to $214.7 million, compare...
Alkermes plc Reports First Quarter 2023 Financial Results PR Newswire — First Quarter Revenues of $287.6 Million Reflect Strong Performance of Proprietary Product Portfolio — — GAAP Loss per Share of $0.25 and Basic and Diluted ...
2023-04-25 09:42:32 ET Alkermes ( NASDAQ: ALKS ) said it received a second interim award from the arbitral tribunal in an arbitration linked to two license agreements with Johnson & Johnson's ( NYSE: JNJ ) unit Janssen Pharmaceutica. Under the second interim ...
Alkermes Announces Second Interim Award in Janssen Pharmaceutica Arbitration PR Newswire DUBLIN , April 25, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that on April 19, 2023 it received a second interim award (the "Second Interim Awa...
NORTHAMPTON, MA / ACCESSWIRE / April 24, 2023 / Last week, Katie Joyce, VP of Corporate Affairs, participated in a panel discussion at this year's Women in Bio (WIB) Management Track event featuring women leaders in life science. This year's event gave attendees the opportunity to connect with i...
2023-04-24 05:31:06 ET Summary Biotech stocks have been consolidating recently but may be ready to rally higher due to factors such as a declining 10-year yield and growing M&A activity. Biotech deal-making has been increasing, with large acquisitions such as Pfizer's acquisit...
News, Short Squeeze, Breakout and More Instantly...
Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...
2024-06-29 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-19 17:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...